No credit card. No commitment.
5000+ G2 reviews
ApoVax's financial review
ApoVax's Revenue (Yearly)
1.4M
Employees
1
ApoVax information
ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville.ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants. ApoVax104 can be mixed with or conjugated to any biotinylated antigen (or peptide)--cancer or infectious disease. ApoVax is also developing A...
ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville.ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants. ApoVax104 can be mixed with or conjugated to any biotinylated antigen (or peptide)--cancer or infectious disease. ApoVax is also developing ApoFasL—a means of immunomodulation for tolerance induction—for the treatment of Type 1 diabetes.
ApoVax industries
Biotechnology
Bio-pharm
Life sciences
ApoVax's financial review
ApoVax's Revenue (Yearly)
1.4M
Employees
1
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
